Subcellular localization of rat gastric phospholipase A2.

Biochim Biophys Acta

Institut National de la Santé et de la Recherche Médicale, Unité 130, Marseille, France.

Published: March 1991

In the present study, we have performed experiments to gain some insight into the subcellular localization and biochemical properties of gastric mucosal phospholipase A2. After classical subcellular fractionation of whole glandular stomach mucosa, we found that gastric phospholipase A2 was essentially enriched in the 105,000 x g pellet that contains microsomes and plasma membranes. Except for the cytosol, all the subcellular fractions exhibited similar phospholipase A2 activity (i.e., optimum of pH, calcium dependence, apparent Km and positional specificity). The high-speed pellet was further characterized by ultracentrifugation on a sucrose gradient. Data showed that the sedimentation profile of phospholipase A2 was quite similar to those of plasma membrane markers and more specifically to an apical membrane marker. These results, taken together, showed that a gastric phospholipase A2 is distributed among the various subcellular fractions (as a result of cross-contamination) together with the membrane fraction on which it is associated. It is proposed that this fraction is the apical plasma membrane which would be the main site of phospholipase A2 action for arachidonic acid release. Lysophospholipase showed the same sedimentation profile as phospholipase A2, whereas acyl CoA-lysophosphatidylcholine: acyltransferase mainly sedimented with heavy microsomes. The substrate specificity of the enzyme was assessed by endogenous hydrolysis of gastric mucosal phospholipids. We were able to show that the enzyme acts at nearly the same rate on two major gastric membrane phospholipids, namely phosphatidylcholine and phosphatidylethanolamine.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0005-2760(91)90186-lDOI Listing

Publication Analysis

Top Keywords

gastric phospholipase
12
subcellular localization
8
phospholipase
8
gastric mucosal
8
subcellular fractions
8
sedimentation profile
8
profile phospholipase
8
plasma membrane
8
gastric
6
subcellular
5

Similar Publications

Article Synopsis
  • N-Acylethanolamines (NAEs) are lipid mediators important for reducing inflammation and suppressing appetite, with palmitoylethanolamide (PEA) and arachidonoylethanolamide (AEA) interacting with specific receptors.
  • The enzyme PLAAT5 is highlighted as crucial for producing NAEs in testes, as research using PLAAT5-deficient mice revealed a significant drop in NAE levels and their associated anti-inflammatory effects.
  • Inflammation in testicular tissue was exacerbated in PLAAT5-deficient mice but could be mitigated by PEA and AEA, indicating that these compounds could provide protective roles through their receptor pathways.
View Article and Find Full Text PDF

The bioaccessibility and bioavailability of dietary fatty acids depend on the lipid to which they are esterified, the organisation of theses lipids in water and their recognition by lipolytic enzymes. In this work, we studied the release of marine long-chain polyunsaturated fatty acids (LC-PUFA), depending on their presentation either in the form of phospholipids (PL) or triacylglycerol (TAG). Two formulations based on marine PL or TAG extracted from salmon heads () were prepared.

View Article and Find Full Text PDF

Effects of phospholipase D1-inhibitory peptide on the growth and metastasis of gastric cancer cells.

Mol Cells

November 2024

Department of Biomedical Sciences, Graduate School for Biomedical Science & Engineering, Hanyang University, Seoul 04763, Republic of Korea; Biomedical Research Institute and Department of Biochemistry & Molecular Biology, College of Medicine, Hanyang University, Seoul, Republic of Korea. Electronic address:

Article Synopsis
  • Phospholipase D1 (PLD1) is linked to cancer development and progression, affecting key processes like cell growth, survival, invasion, and drug resistance, making it a target for new cancer therapies.
  • The study tested a novel peptide inhibitor, TAT-TVTSP, which combines PLD1 inhibition with cell-penetrating capabilities, showing effective inhibition of PLD1 activity in gastric cancer cells and leading to cell cycle arrest without causing cell death.
  • Results demonstrated that TAT-TVTSP not only impaired the ability of gastric cancer cells to proliferate, migrate, and invade but also reduced tumor growth in an animal model, indicating its potential as a new therapeutic option for cancers involving PLD1.
View Article and Find Full Text PDF

Tirzepatide as an innovative treatment strategy in a pre-clinical model of obesity-driven endometrial cancer.

Gynecol Oncol

December 2024

Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Electronic address:

Objective: Interventions that combat obesity and its associated metabolic perturbations may decrease incidence and improve outcomes of endometrial cancer (EC). Potential options for weight loss include pharmacotherapeutic interventions such as tirzepatide, a dual-acting glucagon-like peptide 1 (GLP-1) and gastric inhibitory polypeptide (GIP) receptor agonist. Given this, we explored the anti-obesity and anti-tumorigenic effects of tirzepatide in our pre-clinical mouse model of endometrioid EC.

View Article and Find Full Text PDF
Article Synopsis
  • Primary atopic disorders (PAD) are rare genetic conditions caused by specific gene variants that affect skin and immune function, making diagnosis challenging among common allergic disease cases.
  • Identifying PAD requires recognizing clinical red flags like family history and unusual infections, as conventional lab tests are inadequate for definitive diagnosis.
  • Whole-genome sequencing (WGS) enhances diagnostic efficiency and accuracy, but requires careful interpretation and collaboration among specialists to effectively manage PAD cases.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!